Ignacio Puche Sanz-rekin lankidetzan egindako argitalpenak (5)

2022

  1. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

    Theranostics, Vol. 12, Núm. 5, pp. 2150-2161

2021

  1. Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation

    Cancers, Vol. 13, Núm. 6, pp. 1-21

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701